Protein lysine acetyltransferase CBP/p300: A promising target for small molecules in cancer treatment

This publication has 136 references indexed in Scilit:

• Differences in Specificity and Selectivity Between CBP and p300 Acetylation of Histone H3 and H3/H4
  Biochemistry, 2013
• High expression of p300 is linked to aggressive features and poor prognosis of Nasopharyngeal Carcinoma
  Journal of Translational Medicine, 2012
• Leptin-induced Epithelial-Mesenchymal Transition in Breast Cancer Cells Requires β-Catenin Activation via Akt/GSK3- and MTA1/Wnt1 Protein-dependent Pathways
  Journal of Biological Chemistry, 2012
• MYC on the Path to Cancer
  Cell, 2012
• Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell Lines
  Molecular Cancer Therapeutics, 2011
• Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor
  Chemistry & Biology, 2010
• Cyclic AMP-Responsive Element Binding Protein– and Nuclear Factor-κB–Regulated CXC Chemokine Gene Expression in Lung Carcinogenesis
  Cancer Prevention Research, 2008
• Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis
  Nature Cell Biology, 2008
• CBP/p300 histone acetyl-transferase activity is important for the G1/S transition
  Oncogene, 2000
• The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
  Cell, 1996